Impact of synthetic biology and metabolic engineering on industrial production of fine chemicals
Artikel i vetenskaplig tidskrift, 2015

© 2015 Elsevier Inc. Industrial bio-processes for fine chemical production are increasingly relying on cell factories developed through metabolic engineering and synthetic biology. The use of high throughput techniques and automation for the design of cell factories, and especially platform strains, has played an important role in the transition from laboratory research to industrial production. Model organisms such as Saccharomyces cerevisiae and Escherichia coli remain widely used host strains for industrial production due to their robust and desirable traits. This review describes some of the bio-based fine chemicals that have reached the market, key metabolic engineering tools that have allowed this to happen and some of the companies that are currently utilizing these technologies for developing industrial production processes.

Saccharomyces cerevisiae

Escherichia coli

Synthetic biology

Cell factories

Metabolic engineering

Industrial production

Författare

David Jullesson

Chalmers, Biologi och bioteknik, Systembiologi

Florian David

Chalmers, Biologi och bioteknik, Systembiologi

B. F. Pfleger

University of Wisconsin Madison

Jens B Nielsen

Chalmers, Biologi och bioteknik, Systembiologi

Biotechnology Advances

0734-9750 (ISSN)

Vol. 33 7 1395-1402

Ämneskategorier

Industriell bioteknik

Bioinformatik och systembiologi

Styrkeområden

Energi

Livsvetenskaper och teknik

Infrastruktur

C3SE (Chalmers Centre for Computational Science and Engineering)

DOI

10.1016/j.biotechadv.2015.02.011

Mer information

Senast uppdaterat

2018-10-15